Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Heine

Showing results (621-630 of 636) with videos related to

Pageof 64
Sort By:
Breast Cancer Research and Treatment|January 23, 2013
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancerAntoinette Hollestelle, Justine K Peeters, Marcel Smid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 3, 2017
Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase InhibitorsNatalie J Engmann, Christopher G Scott, Matthew R Jensen, et al.
Journal of Hypertension|January 7, 2010
The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studiesLian Engelen, Isabel Ferreira, Katrien H J Gaens, et al.
Diabetes|October 17, 2009
Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell functionAnnemarie M Simonis-Bik, Giel Nijpels, Timon W van Haeften, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemiaMartin Heni, Caroline Ketterer, Leen M 't Hart, et al.
European Journal of Human Genetics : EJHG|February 12, 2009
Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE studyErwin Reiling, Jana V van Vliet-Ostaptchouk, Esther van 't Riet, et al.
European Journal of Clinical Nutrition|January 28, 2005
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populationsA de Bree, N M J van der Put, L I Mennen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 18, 2012
Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in menD H van Raalte, N van Leeuwen, A M Simonis-Bik, et al.
Diabetes|October 8, 2009
Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clampsLeen M 't Hart, Annemarie M Simonis-Bik, Giel Nijpels, et al.
Lancet (London, England)|October 11, 2005
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialJohn A Dormandy, Bernard Charbonnel, David J A Eckland, et al.
Pageof 64

Showing results (621-630 of 636) with videos related to

Sort By:
Pageof 64
Breast Cancer Research and Treatment|January 23, 2013
Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancerAntoinette Hollestelle, Justine K Peeters, Marcel Smid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 3, 2017
Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase InhibitorsNatalie J Engmann, Christopher G Scott, Matthew R Jensen, et al.
Journal of Hypertension|January 7, 2010
The association between the -374T/A polymorphism of the receptor for advanced glycation endproducts gene and blood pressure and arterial stiffness is modified by glucose metabolism status: the Hoorn and CoDAM studiesLian Engelen, Isabel Ferreira, Katrien H J Gaens, et al.
Diabetes|October 17, 2009
Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell functionAnnemarie M Simonis-Bik, Giel Nijpels, Timon W van Haeften, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemiaMartin Heni, Caroline Ketterer, Leen M 't Hart, et al.
European Journal of Human Genetics : EJHG|February 12, 2009
Genetic association analysis of 13 nuclear-encoded mitochondrial candidate genes with type II diabetes mellitus: the DAMAGE studyErwin Reiling, Jana V van Vliet-Ostaptchouk, Esther van 't Riet, et al.
European Journal of Clinical Nutrition|January 28, 2005
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populationsA de Bree, N M J van der Put, L I Mennen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 18, 2012
Glucocorticoid receptor gene polymorphisms are associated with reduced first-phase glucose-stimulated insulin secretion and disposition index in women, but not in menD H van Raalte, N van Leeuwen, A M Simonis-Bik, et al.
Diabetes|October 8, 2009
Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clampsLeen M 't Hart, Annemarie M Simonis-Bik, Giel Nijpels, et al.
Lancet (London, England)|October 11, 2005
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialJohn A Dormandy, Bernard Charbonnel, David J A Eckland, et al.
Pageof 64